Vidyya Medical News Service
*
Volume 7 Issue 52 Published - 14:00 UTC 08:00 EST 21-Feb-2005 Next Update - 14:00 UTC 08:00 EST 22-Feb-2005
little clear gif used for spacer
.
*

Familiar blood pressure drug may prevent osteoporosis
A form of beta blocker, a drug commonly used to lower blood pressure and ward off repeat heart attacks, may provide the answer to preventing osteoporosis, said a Baylor College of Medicine researcher. more

*
Mathematical model predicts live-saving benefits of different mammography screening schedules
Researchers at Dana-Farber Cancer Institute in Boston have devised a mathematical tool that predicts how the frequency of mammograms affects the number of lives saved by detecting breast cancers at an earlier stage.  more

*
Air pollution thickens blood and boosts inflammation
Air pollution, and especially particulate matter, thickens the blood and boosts inflammation, finds experimental research in Occupational and Environmental Medicinemore

 


*
Regular cannabis may increase risk of stroke in young users
Regular users of cannabis could be putting themselves at risk of stroke, while they are still young, indicates a case report, published in the Journal of Neurology Neurosurgery and Psychiatry.  more

*
Component of green tea protects injured livers in mice
A new study investigating the effects of the major flavonoid component of green tea on hepatic steatosis (fatty liver) found that it significantly protected livers that suffered ischemia/reperfusion (I/R) injury in mice. I/R injury, which is caused by decreased blood flow, can lead to complications after liver transplantation.  more

*
FDA approves new plasma-derived product to treat complications of smallpox vaccination
FDA has approved Vaccinia Immune Globulin Intravenous (VIGIV) -- the first intravenous human plasma-derived product available to treat certain rare complications of smallpox vaccination.  more

*
Prescribing information: Vaccinia Immune Globulin Intravenous (VIGIV)
NIGIV is the first intravenous human plasma-derived product available to treat certain rare complications of smallpox vaccination. The product is used in the treatment and modification of aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in cases of isolated keratitis), mouth, or other areas where vaccinia infection would constitute a special hazard; eczema vaccinatum; progressive vaccinia; severe generalized vaccinia, and vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions. more

 
little clear gif used for a space